Testosterone Products

Testosterone replacement therapy lawsuits are being reviewed against the makers of:

• AndroGel: One of the most widely used testosterone treatments, which is a spray gel applied to the shoulder or upper arms. Since it was first introduced in 2000, it has been aggressively marketed by AbbVie in direct-to-consumer advertisements for treatment of “Low T”.
• AndroDerm: A testosterone patch introduced in 1995 by Actavis, which is warn on the skin.
• Axiron: A testosterone gel introduced by Eli Lilly in 2010, which is applied to the armpits in a manner similar to deodorant.
• Bio-T Gel: A once-daily testosterone treatment gel that was approved in February 2012, but is not widely used.
• Delatestryl: A testosterone injection treatment introduced by Endo Pharmaceuticals in 2008, which is injected into the buttock muscle usually every 1 to 4 weeks.
• Depo-Testosterone: Injection testosterone replacement therapy that was introduced by Pfizer in 2006, and is not available as a generic testosterone shot.
• Foresta: A testosterone spray gel that is applied to the thigh daily, which was introduced by Endo Pharmaceuticals in December 2010.
• Testim: A gel treatment for testosterone replacement that is applied to the shoulders daily. It was introduced in 2002 by Auxilium and is widely used.
• Testopel: A testosterone pellet that was first introduced in 1972 and is sold by Auxilium. The testosterone implant is placed under the skin, releasing testosterone over a period of 3 to 6 months.
• Striant: A testosterone supplement sold by Auxilium that adheres to the gums and is placed twice daily.

According to allegations that will be raised in complaints or lawsuits filed throughout the United States, the makers of these low testosterone medications placed their desire for profits before the safety and health of consumers by:

• Failing to adequately research the risk of stroke or heart attack from testosterone therapy, especially among men with cardiovascular disease, high cholesterol, blocked arteries, diabetes, obesity and other prior heart problems.
• Recklessly marketing testosterone treatments in direct-to-consumer advertisements that encourage otherwise health men to seek prescription medications for “Low T” if they are experiencing any number of general symptoms, such as lack of energy, weight gain, decreased sex drive and other natural issues experienced by men as they age.
• Withholding information from consumers and the medical community about the heart risk of testosterone treatments.

All cases are reviewed and handled by our law firm under a contingency fee agreement, which means that there are no fees or expenses for the client unless our injury lawyers are successful obtaining a recovery in your case.